Raleigh Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.9K Sell
199
-39
-16% -$14.5K 0.02% 252
2026
Q1
$69.6K Buy
238
+4
+2% +$1.31K 0.02% 258
2025
Q4
$82K Sell
234
-70
-23% -$23.7K 0.03% 248
2025
Q3
$98.2K Buy
304
+26
+9% +$8.09K 0.04% 232
2025
Q2
$108K Buy
278
+55
+25% +$22.1K 0.05% 232
2025
Q1
$97K Sell
223
-19
-8% -$7.63K 0.04% 233
2024
Q4
$89.4K Sell
242
-17
-7% -$7.11K 0.03% 262
2024
Q3
$134K Sell
259
-196
-43% -$105K 0.05% 233
2024
Q2
$247K Buy
455
+222
+95% +$117K 0.11% 178
2024
Q1
$121K Buy
233
+46
+25% +$22.9K 0.05% 231
2023
Q4
$88.4K Sell
187
-487
-72% -$225K 0.04% 230
2023
Q3
$293K Buy
674
+18
+3% +$8.16K 0.15% 135
2023
Q2
$291K Buy
656
+64
+11% +$29.5K 0.15% 145
2023
Q1
$272K Buy
592
+449
+314% +$214K 0.13% 149
2022
Q4
$73.5K Hold
143
0.04% 225
2022
Q3
$65K Hold
143
0.04% 223
2022
Q2
$69K Buy
143
+1
+0.7% +$495 0.04% 231
2022
Q1
$70K Buy
+142
New +$64.9K 0.04% 238

Other funds holding ELV

Raleigh Capital Management's ELV Position: Q2 2026 in Review

Raleigh Capital Management reduced its Elevance Health (ELV) stake by 16% in Q2 2026, selling an estimated $14.5K and leaving 199 shares worth $76.9K. The position accounts for 0.02% of the portfolio, ranked #252.

Raleigh Capital Management first reported a position in ELV in Q1 2022 and has held it in 18 quarters since. The position peaked at $293K in Q3 2023. 368 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Raleigh Capital Management held 199 shares of Elevance Health worth $76.9K as of Q2 2026.
  • Raleigh Capital Management sold 39 Elevance Health shares in Q2 2026, an estimated $14.5K.
  • Elevance Health made up 0.02% of Raleigh Capital Management's portfolio in Q2 2026, its #252 holding.
  • Raleigh Capital Management first reported a position in Elevance Health in Q1 2022 and has held it in 18 quarters since.
  • Raleigh Capital Management's Elevance Health position peaked at $293K in Q3 2023.
  • 368 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.